Long-term Management of Advanced CRC: An Interactive Patient Case
Long-term Management of Advanced CRC: An Interactive Patient Case
Which clinical decisions will you make?
Which clinical decisions will you make?
Assoc. Prof. Gerald Prager, Assoc. Prof. Joleen Hubbard
In this interactive patient case study, developed by Assoc. Prof Gerald Prager and Assoc. Prof. Joleen Hubbard, you'll learn about the management of colorectal cancer (CRC) to achieve a long-term response. As you work through the two patient cases, you'll make treatment decisions at key points and receive feedback on your choices, with references to supporting data.
After taking part, you'll understand:
- How to view CRC treatment as a continuum of care
- What to consider when making treatment decisions
- Which treatment options are available for CRC patients 3rd line and beyond
Take the interactive patient case programme below or follow the link to take the accredited e-learning to count towards your CME credit.
Assoc. Prof. Gerald Prager
Medical Oncologist
Medical University of Vienna
Austria
Assoc. Prof. Joleen Hubbard
Medical Oncologist
Allina Health Cancer Institute
United States (US)
Long term management of advanced colorectal cancer
| 
30 min
|
Jul 2023
This programme was made for you: your opinion matters
Share your feedback in just 4 clicks and help us to continue to create the content you need.
I agree that this educational programme:
Clinical Takeaways
-
Treatment of advanced colorectal cancer (CRC) should be considered as a continuum of care and patients should be offered as many life prolonging therapies as possible
-
Decision-making at each stage of therapy should consider patients' suitability and tolerability, tumour biomarkers and prior exposure to chemotherapies and/or targeted agents
-
There are a number of treatment options for CRC patients third-line and beyond which should be considered such as regorafenib, trifluridine/tipiracil as well as consideration of clinical trials and rechallenge with chemotherapy or anti-EGFR
This programme is endorsed by:
Digestive Cancers Europe (DiCE) is a European non-profit umbrella organisation of nearly 40 national Member Organisations across Europe representing patients with digestive cancers – colorectal, gastric, liver, oesophageal, pancreatic, and rare digestive cancers. DiCE is committed to advancing diagnosis and medical treatment, advocating high standards in clinical practice, education, and research, and supporting patient care for a better quality of life. DiCE's vision is to see fewer people in Europe suffering from digestive cancers.
This educational programme is supported by an Independent Medical Education Grant from Bayer
GI CONNECT is an initiative of COR2ED, supported by an Independent Educational Grant from Bayer.
Other programmes of interest
2 min
Other programmes developed by Assoc. Prof. Gerald Prager
Assoc. Prof. Gerald Prager
Medical Oncologist
Medical University of Vienna
Austria
Other programmes developed by Assoc. Prof. Joleen Hubbard
Assoc. Prof. Joleen Hubbard
Medical Oncologist
Allina Health Cancer Institute
United States (US)
